SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+5.87%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$671M
AUM Growth
+$671M
(-4.5%)
Cap. Flow
-$75.2M
Cap. Flow
% of AUM
-11.21%
Top 10 Holdings %
Top 10 Hldgs %
36.87%
Holding
176
New
35
Increased
31
Reduced
45
Closed
50
Top Buys
| 1 |
Biogen
BIIB
|
$20.5M |
| 2 |
CELG
Celgene Corp
CELG
|
$10.4M |
| 3 |
CXRX
Concordia International Corp. Common Stock
CXRX
|
$9.03M |
| 4 |
BCOM
B Communications Ltd
BCOM
|
$6.45M |
| 5 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$5.32M |
Top Sells
| 1 |
ENDP
Endo International plc
ENDP
|
$18.8M |
| 2 |
Perrigo
PRGO
|
$16.3M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$13.3M |
| 4 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$12.5M |
| 5 |
Amgen
AMGN
|
$9.21M |
Sector Composition
| 1 | Healthcare | 77.22% |
| 2 | Technology | 6.01% |
| 3 | Utilities | 2.06% |
| 4 | Industrials | 1.46% |
| 5 | Consumer Discretionary | 1.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMAG
26
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $6.23M | 0.61% | 90,230 -110,000 | -55% | -$7.6M |
|
27
Prothena Corp
PRTA
$441M
| $6.06M | 0.59% | 115,133 +27,000 | +31% | +$1.42M |
|
|
ARRY
28
DELISTED
Array Biopharma Inc
ARRY
| $5.77M | 0.57% | 800,000 -123,922 | -13% | -$893K |
|
|
FWP
29
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $5.71M | 0.56% | 150,000 -30,000 | -17% | -$1.14M |
|
30
iShares MSCI Germany ETF
EWG
$2.54B
| $5.37M | 0.53% | 192,630 +84,630 | +78% | +$2.36M |
|
|
GWPH
31
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $5.34M | 0.52% | 43,500 +8,500 | +24% | +$1.04M |
|
|
CYNA
32
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $5.32M | 0.52% | +316,448 | New | +$5.32M |
|
33
Insmed
INSM
$28.8B
| $5.25M | 0.51% | 215,000 -35,000 | -14% | -$855K |
|
|
MDCO
34
DELISTED
Medicines Co
MDCO
| $5.15M | 0.5% | 180,000 +80,000 | +80% | +$2.29M |
|
|
TSRO
35
DELISTED
TESARO, Inc.
TSRO
| $5.14M | 0.5% | +87,500 | New | +$5.14M |
|
36
Astria Therapeutics
ATXS
$349M
| $5.06M | 0.5% | +446,036 | New | +$5.06M |
|
37
United Therapeutics
UTHR
$13.8B
| $5.02M | 0.49% | 28,840 -20,000 | -41% | -$3.48M |
|
|
ACOR
38
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $5M | 0.49% | +150,000 | New | +$5M |
|
39
Catalyst Pharmaceutical
CPRX
$2.52B
| $4.96M | 0.49% | 1,200,000 +100,000 | +9% | +$413K |
|
|
BLCM
40
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $4.92M | 0.48% | 231,514 -18,053 | -7% | -$384K |
|
41
Ultragenyx Pharmaceutical
RARE
$2.89B
| $4.88M | 0.48% | +47,700 | New | +$4.88M |
|
42
Sarepta Therapeutics
SRPT
$1.78B
| $4.57M | 0.45% | +150,000 | New | +$4.57M |
|
43
Aptiv
APTV
$17.3B
| $4.52M | 0.44% | +53,070 | New | +$4.52M |
|
|
ORBK
44
DELISTED
Orbotech Ltd
ORBK
| $4.47M | 0.44% | 214,922 +18,300 | +9% | +$381K |
|
45
Alnylam Pharmaceuticals
ALNY
$58.5B
| $4.44M | 0.43% | +37,000 | New | +$4.44M |
|
|
RLYP
46
DELISTED
RELYPSA INC COM
RLYP
| $4.37M | 0.43% | 132,000 -3,000 | -2% | -$99.3K |
|
47
Zevra Therapeutics
ZVRA
$509M
| $4.36M | 0.43% | +237,500 | New | +$4.36M |
|
|
ICPT
48
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $4.22M | 0.41% | 17,500 +2,500 | +17% | +$603K |
|
|
GNCA
49
DELISTED
Genocea Biosciences, Inc.
GNCA
| $4.15M | 0.41% | 302,200 +178,000 | +143% | +$2.44M |
|
|
ITCI
50
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.09M | 0.4% | 128,000 -22,000 | -15% | -$703K |
|